COVID-19 Pandemic in the Region of the Americas
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
z
COVID-19 Pandemic in the Region of the Americas
z Slide No.
Global Situation
(as of 4 January 10H CET)
Global Overview
As of 22 March:
• More than 122 million cases of
COVID-19 including
approximately 2.7 million
deaths have been reported
worldwide.
• Of the total, nearly 3.3 million
cases including 60,257 deaths
were reported in the past week
• PAHO represents the 36% of the
global cases and 52% of global
deaths
Global Situation
(as of 4 January 10H CET) Global Overview
The global cases and deaths
are once more increasing
after a six-week period of
sustained decline between
EW 1 and EW 7 of 2021
Globally, of the top 10
countries reporting the
highest number of new
covid-19 cases in the past
week, the top two are from
the region of the Americas –
Brazil & the United States of
America
Epidemiological Week of report
https://covid19.who.int/
4
Region of the Americas: COVID-19 CASES
As of 22 March:
• Close to 54 million cases of COVID-19
including 1.3 million deaths have been
reported in the region of the Americas from
all 54 countries and territories.
• Cases peaked in EW 1 of 2021 (January) after
which there was a sustained decline for six
consecutive weeks.
• However, since then, weekly cases have
stagnated around 1 million for the past 4
weeks.
• This is mainly due to the epidemic behavior of
the two biggest contributors – the United
States where the weekly decline in cases has
Previous week: stagnated for the past four weeks and Brazil,
1,173,561 new confirmed cases from 49 countries. where the weekly cases have been increasing
31,040 new deaths from 33 countries. for the past five weeks.
35.8% of new global cases
51.5% of new global deaths
5
• Besides the United States, in the other two
countries of the north American subregion, the
new weekly cases decreased by 22% in Mexico
(30,139 cases) (light blue color) and increased by
11%% (632 new cases) in Canada (orange color)
relative to the previous week.
• New weekly cases have also increased between
10%-50% (orange color) in several
countries/territories belonging to other subregions
in the Americas such as Guatemala in Central
America, Chile, Paraguay and Uruguay in South
America &, all the countries in the Andean sub-
region.
• In the Caribbean sub-region, six
countries/territories reported an increase of
greater than or equal to 50% compared to the
previous week (Curacao, Bonaire, Turks and Caicos
Islands, Bermuda, and Grenada).
6
Region of the Americas: COVID-19 DEATHS
As of March 22:
After four consecutive
weeks of decline in the
weekly deaths in the
region, it increased
slightly again in
epidemiological week 11
driven primarily by Brazil.
The weekly deaths
continue to decline in the
United States and Mexico
for the fifth consecutive
week.
7
• In the past week, Brazil had the highest mortality rate
(72 deaths per 1 million population) followed by Peru,
Chile and Paraguay.
• In terms of relative change compared to the previous
week, many countries experienced 20% or higher
increase in deaths across all subregions in the
Americas: Guatemala (20%) and Honduras (24%) in
Central America; Bolivia (21%), and Colombia (26%) in
the Andean Region and Brazil (23%), & Paraguay
(43%) and Uruguay (37%) in South America.
• In the Caribbean subregion – Curacao, Guadeloupe,
Aruba, Barbados, Haiti and Saint Vincent and the
Grenadines all experienced an increase of 100% or
higher in their weekly number of deaths compared to
the previous week.
8
VARIANTS IN THE REGION
Reporting all 3 VOCs
Reporting all 2 VOCs
Countries and territories in the
region of the Americas that
have reported at least one case
of the three Variants of
Concern (VOC) as defined by
the WHO. As of 23 March 2021.
Reporting all 1 VOC
Source: Data provided by ministries of Health via IHR channels
and/or EBS surveillance.
Illustrative Country Indicators All 35 countries have: • Functioning multi-sectoral, multi- partner coordination mechanism for COVID-19 • In-country capacity or access to international laboratory (e.g., CARPHA) that can provide results within 72 hours • Clinical referral system in place to care for COVID-19 cases
Analysis of 4 countries (ICUs)
as of 17 November 2020 PENDING UPDATE FOR 2021
Impact on Health Services – ICU beds
Increase Peru Chile Colombia Mexico Total
Baseline/March 820 1,500 5,845 2,446 10,611
1-Jul 1,335 2,780 6,898 6,853 17,866
141.4%
31-Jul 1,618 3,051 8,968 11,634 25,271
30-Sep 1,725 2,556 10,443 10,657 25,381 Increase in the
17-Nov 1,479 2,229 11,253 10,657 25,618
capacity of ICUs
Increase Peru Chile Colombia Mexico Total Peru Chile Colombia Mexico Occupancy
Baseline 80% 80% 45% 45%
17-Nov 80.4% 48.6% 92.5% 335.7% 141.4% rate
64%
1-Jul 80% 90% 62% 50%
31-Jul 88% 81% 75% 55%
ICU beds 30-Sep 82% 82% 73% 72%
17-Nov 67% 84% 55% 72%
10,611 17,866 25,271 25,381 25,618
In use Avalaible
11,634
11,253
10,657
10,657
10,443
Average
67% 74% 65%
8,968
occupancy
6,898
6,853
63% rate
5,845
8250 6499 8810
52%
3,051
2,780
2,556
6593
2,446
2,229
1,725
1,618
1,500
1,479
1,335
18,882
820
5024 16,951 16,808
11,274
5,587
BASE 1-JUL 31-JUL 30-SEP 17-NOV
LINE/MARCH BASE 1-JUL 31-JUL 30-SEP 17-NOV
Peru Chile Colombia Mexico LINE/MARCHCOVID-19 Response
177 198
15,681 1,359
As of 10 March 2021z
COVID-19 Key Challenges
By Strategic Area
z Slide No.COVID-19 Key Challenges
By Strategic Area
Surveillance, Rapid Response Points of Entry, international
Teams, and Case Investigation travel, and transport
Country surveillance systems have Limited ability of the health sector to influence
challenges to adapt and expand decision-making related to the measures to
capacities against a backdrop of varying mitigate risks associated with resuming non-
transmission intensity, variant emergence, essential international travel, including in relation
to testing and proof of vaccination for travelers.
and vaccine introduction.COVID-19 Key Challenges
By Strategic Area
Infection Prevention
National Laboratories
and Control
• Limited capacity to implement national
• Limited in-country capacity to to rapidly regulatory IPC frameworks: governance,
identify and report variants of concern guidelines, education and training, HAI
(VOC). surveillance, multimodal strategies, and
M&E of IPC practices.COVID-19 Key Challenges
By Strategic Area
Operational
Case Management
Support and Logistics
Lack of sufficient and sustained resources for the
Adapting/managing health services networks to deliver
timely procurement and distribution of vaccines,
optimized standard of care for all COVID-19 patients in a
rational, sustainable and evidence-based manner. PPEs, equipment and diagnostic supplies to priority
countries and emergency hotspotsCOVID-19 Key Challenges
By Strategic Area
Maintaining Essential Health Services and Systems
during the Pandemic
• Limited investment in the first level of care to increase
resolution capacity, including human resources (with adequate
training and PPE), medicines and other health technologies, for
a comprehensive response during the pandemic (essential health
services and COVID-19 related services).
• Ensuring safe and decent working conditions for health care
workers, including equal pay, access to PPE, training, and access
to support services (including mental health).
• Lack or limited legal provisions for authorizing medicines and
other health technologies for emergency use that result in a
negative impact on the supply chain.COVID-19 Key Challenges
By Strategic Area
Vaccination
• Reaching priority groups in the different stages of
vaccination, within the context of limited vaccine
availability.
• Limited in-country operational capacity to guarantee
the financial, human and related necessary resources
to ensure COVID-19 vaccine deployment.
• Ensuring that COVID-19 vaccination strengthens
routine immunization programs to avoid the
reemergence of vaccine preventable diseases.z
COVID-19 Pandemic in the Region of the Americas
z Slide No.You can also read
